Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-04-15
2008-04-15
Crouch, Deborah (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S459000, C424S184100
Reexamination Certificate
active
07358234
ABSTRACT:
The present invention relates to a process for inducing a protective immune response in a mammal against a virus, in which a construct including a promoter and a DNA sequence encoding a protein or peptide producing an immune response against the virus is introduced into muscle or skin of the mammal via a microprojectile. Sufficient amounts of the construct are administered so as to produce a protective immune response in the mammal.
REFERENCES:
patent: 3931397 (1976-01-01), Harnden
patent: 4224404 (1980-09-01), Viza et al.
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4689320 (1987-08-01), Kaji
patent: 4699880 (1987-10-01), Goldstein
patent: 4704692 (1987-11-01), Ladner
patent: 4738927 (1988-04-01), Taniguchi et al.
patent: 4761375 (1988-08-01), Clark
patent: 4798786 (1989-01-01), Tice et al.
patent: 4806463 (1989-02-01), Goodchild et al.
patent: 4870009 (1989-09-01), Evans et al.
patent: 4944942 (1990-07-01), Brown et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 5100792 (1992-03-01), Sanford et al.
patent: 5204253 (1993-04-01), Sanford et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5703057 (1997-12-01), Johnston et al.
patent: 6194389 (2001-02-01), Johnston et al.
patent: 6710035 (2004-03-01), Felgner et al.
patent: 2004/0092019 (2004-05-01), Johnston et al.
patent: 0 270 356 (1988-06-01), None
patent: 0 301 749 (1989-02-01), None
patent: 0 465 529 (1992-01-01), None
patent: 7781 (1970-03-01), None
patent: 86/00930 (1986-02-01), None
patent: 91/00359 (1991-01-01), None
patent: 91/07487 (1991-05-01), None
patent: 95/05853 (1995-03-01), None
patent: 97/19675 (1997-06-01), None
patent: 97/37966 (1997-10-01), None
Sanford et al (1987) Particulate Science and Technology 5, 27-37.
Jaffee et al. Gene Therapy: It's Potential Applications in the Treatment of Renal-Cell Carcinoma. Seminars in Oncology. 1995, vol. 22, pp. 81-91.
Beddow Particulate science and technology pp. 3-37, vol. 5, No. 1, 1987.
Journal of Cellular Biochemistry, UCLA Symposia on Molecular & Cellular Biology, Abstracts, 19thAnnual Meetings, Jan. 1990, Alan R. Liss, Inc.
Transcript of speech entitled “Particle Propulsion by electric Discharge at the AAAS Meeting on Plant Molecular Biology/Genetic Engineering for Agriculture (VI)”, Jan. 1989, by Winston Brill. Tape available from AAAS.
G. Acsadi et al., “Direct Gene Transfer and Expression into Rat Heart in Vivo”, The New Biologist, Jan. 1991, pp. 71-81, vol. 3, No. 1.
W.F. Anderson, “Gene Therapy—Several hundred patients have already received treatment. In the next century the procedure will be commonplace”, Scientific American, Sep. 1995, pp. 124-128, Scientific American Inc., New York, NY.
P. Anker et al., “The Role of Extracellular DNA in the Transfer of Information From T to B Human Lymphocytes in the Course of an Immune Response”, J. Immunogenet, 1980, pp. 475-481, vol. 7, Blackwell Scientific Publications.
P. Anker et al., “Nude Mice Injected with DNA Excreted by Antigen-Stimulated Human T Lymphocytes Synthesize Specific Human Antibodies”, Expl. Cell. Biol., 1984, pp. 133-136, vol. 52, Karger, Basel.
P. Anker et al., “Transfert d'information de lymphocytes T á B au cours d'une rëponse immune: rôle de l'ADN extracellulaire”, Schweiz. Med. Wschr., 1980, pp. 1444-1446, vol. 110.
P. Anker et al., “Spontaneous Release of DNA by Human Blood Lymphocytes as Shown in an in Vitro System”, Cancer Res., Sep. 1975, pp. 2375-2382, vol. 35.
K. Anwer et al., “Synergistic Effect of Formulated Plasmid and Needle-Free Injection for Genetic Vaccines”, Pharm. Res., 1999, pp. 889-895, vol. 16, No. 6, Plenum Publishing Corporation.
J.D. Appel et al., “Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA”, Proc. Natl. Acad. Sci. USA, 1988, pp. 7670-7674, vol. 85, The National Academy of Sciences, Washington, DC.
R. Aubin et al., “Polybrene/DMSO-Assisted Gene Transfer”, Methods in Molecular Biology, 1991, pp. 35-43, vol. 7, Chapter 4, The Humana Press Inc., Clifton, NJ.
W. Bains, “Anti-idiotype Antibodies”, Biotechnology From A to Z (2d ed.), 1988, pp. 17-19, Oxford University Press.
Baker et al., “The Study of Biology: The Fourth Edition”, 1982, pp. 145-150, Addison-Wesley Publishing Company.
J.A. Bellanti, “Theories of Antibody Formation”, Immunology III, 1985, pp. 154-155, W.B. Saunders Company.
N. Benvenisty et al., “Direct Introduction of genes into rats and expression of the genes”, Proc. Natl. Acad. Sci. USA, Dec. 1986, pp. 9551-9555, vol. 83, The National Academy of Sciences, Washington, DC.
H.M. Blau et al., “Molecular Medicine—Gene Therapy—A Novel Form of Drug Delivery”, The New England J. Med., Nov. 2, 1995, pp. 1204-1207, vol. 333, No. 18, Massachusetts Medical Society.
O.F. Borisova et al., “Secondary structure of nuclear precursors of the informational RNA (pre-mRNA)”, Mol. Biol. (Mosk), Sep.-Oct. 1976, pp. 1094-1102, vol. 10, No. 5.
L. Bouchard et al., “Tumorigenic Activity of Polyoma Virus and SV40 DNAs in Newborn Rodents”, Virology, 1984, pp. 53-64, vol. 135, Academic Press, Inc.
O. Boussif et al., “A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine”, Proc. Natl. Acad. Sci. USA, Aug. 1995, pp. 7297-7301, vol. 92, The National Academy of Sciences, Washington, DC.
J.E. Boynton et al., “Chloroplast Transformation inChlamydomonaswith High Velocity Microprojectiles”, Science, 1988, p. 1534, vol. 240, American Association for the Advancement of Science, Washington, DC.
H.W. Chan et al., “Molecular Cloning of Polyoma Virus DNA inEscherichia coli: Lambda Phage Vector System”, Science, Mar. 1979, pp. 887-892, vol. 203, American Association for the Advancement of Science, Washington, DC.
S.C. Chen et al., “Protective Immunity Induced by Oral Immunization With a Rotavirus DNA Vaccine Encapsulated in Microparticles”, Journal of Virology, Jul. 1998, pp. 5757-5761, vol. 72, No. 7, ASM Press, Washington, DC.
O. Chisholm et al., “Transfection of myeloid cell lines using polybrene/DMSO”, Nucleic Acids Research, 1988, p. 2352, vol. 16, Nol. 5, IRL Press Limited, Oxford, England.
P. Christou et al., “Stable Transformation of Soybean Callus by DNA-Coated Gold Particles,” Plant Physiol., 1988, pp. 671-674, vol. 87, No. 3, American Society of Plant Physiologists.
B. Fields et al., Fields Virology, 1996, p. 2699, vol. 2, Lippincott-Raven Publishers, Philadelphia, PA.
B. Fields et al., Fields Virology, 1996, pp. 46-47, vol. 1, Lippincott-Raven Publishers, Philadelphia, PA.
B.N. Fields et al., “Polyomavirinae and Their Replication”, Fields Virology, 1990, p. 1597, vol. 2, Raven Press, NY, NY.
Y. -K. T. Fung et al., “Tumor induction by direct injection of cloned v-srcDNA into chickens”, Proc. Natl. Acad. Sci. USA, Jan. 1983, pp. 353-357, vol. 80, The National Academy of Sciences, Washington, DC.
E. Fynan et al., “DNA vaccines: Protective Immunizations by Parenteral, Mucosal, and Gene-Gun Inoculations”, Proc. Natl. Acad. Sci. USA, Dec. 1993, pp. 11478-11482, vol. 90, The National Academy of Sciences, Washington, DC.
V.S. Gaitskhoki, “Molecular organization of eukaryotic informational RNA”, Mol. Biol. (Mosk), Jul.-Aug. 1979, pp. 725-751, vol. 13, No. 4.
M.C. Garnett, “Gene-Delivery Systems Using Cationic Polymers”, Crit. Rev. Ther. Drug Carr. Sys., 1999, pp. 147-207, vol. 16, No. 2, Begell House, Inc.
C. Gelinas et al., “Tumorigenic activity of cloned polyoma virus DNA in newborn rats”, Experienta, 1981, pp. 1074-1075, vol. 37, Birkhäuser Verlag, Basel, Germany.
C.K. Goldman et al., “In vitro and in vivo gene delivery mediated by a synthetic polycationic amino polymer”, Nature Biotech., May 1997, pp. 462-466, vol. 15.
C.
Johnston Stephen A.
Sanford John C.
Bingham & McCutchen LLP
Crane Sharon E.
Crouch Deborah
Duke University
E.I. du Pont de Nemours & Company
LandOfFree
Induction of a protective immune response through... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Induction of a protective immune response through..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Induction of a protective immune response through... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2766268